Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment

Canadian Journal of Microbiology

Volumn 54, Issue 9, 2008, Pages 718-724

  Borecká Melkusová, Silvia ^a   Bujdáková, Helena ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Biofilm; Candida albicans; Candida dubliniensis; CSH; Genotype

Indexed keywords

CELL MEMBRANES; HYDROPHOBICITY; SURFACE TREATMENT;

BIOFILM; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CSH; GENOTYPE;

BIOFILMS;

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ANTIMICROBIAL ACTIVITY; BIOASSAY; BIOFILM; FUNGUS; GENOTYPE; HYDROPHOBICITY;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOFILM; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SENSITIVITY; DRY MASS; GENOTYPE; HYDROPHOBICITY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDIASIS; GENOTYPE; HUMANS; HYDROPHOBICITY; MICROBIAL SENSITIVITY TESTS; SURFACE PROPERTIES;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 51549120569     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W08-060     Document Type: Article

References (43)

1. Al-Fattani, M.A., and Douglas, L.J. 2004. Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother. 48: 3291-3297. doi:10.1128/AAC.48.9.3291-3297.2004. PMID: 15328087.
2. Antley, P.P., and Hazen, K.C. 1988. Role of yeast cell growth temperature on Candida albicans virulence in mice. Infect. Immun. 56: 2884-2890. PMID:3049375.
3. Asticcioli, S., Nucleo, E., Perotti, G., Matti, C., Sacco, L., and Pagani, L. 2007. Candida albicans in a neonatal intensive care unit: antifungal susceptibility and genotypic analysis. New Microbiol. 30: 303-307. PMID:17802915.
4. Baillie, G.S., and Douglas, L.J. 2000. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46: 397-403. doi:10.1093/jac/46.3.397. PMID:10980166.
5. Blanco, M.T., Morales, J.J., Lucio, L., Pérez-Giraldo, C., Hurtado, C., and Gómez-García, A.C. 2006. Modification of adherence to plastic and to human buccal cells of Candida albicans and Candida dubliniensis by a subinhibitory concentration of itraconazole. Oral Microbiol. Immunol. 21: 69-72. PMID:16390344.
6. Boucher, H., Mercure, S., Montplaisir, S., and Lemay, G. 1996. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene, 180: 189-196. doi:10.1016/S0378-1119(96)00453- 2. PMID:8973366.
7. Bruzual, I., Riggle, P., Hadley, S., and Kumamoto, C.A. 2007. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. J. Antimicrob. Chemother. 59: 441-450. doi:10.1093/jac/dkl521. PMID:17261564.
8. Bujdáková, H., Melkusová, S., Soji, I., Mokráš, M., and Mikami, Y. 2004. Discrimination between Candida albicans and Candida dubliniensis isolated from HIV-positive patients by using commercial method in comparison with PCR assay. Folia Microbiol. (Praha), 49: 484-490. PMID:15530017.
9. Cao, Y.Y., Cao, Y.B., Xu, Z., Ying, K., Li, Y., Xie, Y., et al. 2005. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob. Agents Chemother. 49: 584-589. doi:10.1128/AAC.49.2.584-589.2005. PMID:15673737.
10. Chandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T., and Ghannoum, M.A. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394. doi:10.1128/JB.183.18.5385-5394.2001. PMID:11514524.
11. Chandra, J., Patel, J.D., Li, J., Zhou, G., Mukherjee, P.K., McCormick, T.S., et al. 2005. Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl. Environ. Microbiol. 71: 8795-8801. doi:10.1128/AEM.71.12.8795-8801.2005. PMID:16332875.
12. de Repentigny, L., Aumont, F., Bernard, K., and Belhumeur, P. 2000. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect. Immun. 68: 3172-3179. doi:10.1128/IAI.68.6.3172-3179.2000. PMID:10816460.
13. Egusa, H., Ellepola, A.N., Nikawa, H., Hamada, T., and Samaranayake, L.P. 2000. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates. J. Oral Pathol. Med. 29: 206-213. doi:10.1034/j.1600-0714.2000.290503.x. PMID:10801037.
14. Ellepola, A.N., and Samaranayake, L.P. 1998. The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cells. Arch. Oral Biol. 43: 879-887. doi:10.1016/S0003-9969(98)00064-8. PMID:9821511.
15. Espinel-Ingroff, A., Barchiesi, F., Cuenca-Estrella, M., Pfaller, M.A., Rinaldi, M., Rodriguez-Tudela, J.L., et al. 2005. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J. Clin. Microbiol. 43: 3884-3889. doi:10.1128/JCM.43.8.3884-3889.2005. PMID:16081926.
16. Glee, P.M., Sundstrom, P., and Hazen, K.C. 1995. Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect. Immun. 63: 1373-1379. PMID:7890397.
17. Glee, P.M., Cutler, J.E., Benson, E.E., Bargatze, R.F., and Hazen, K.C. 2001. Inhibition of hydrophobic protein-mediated Candida albicans attachment to endothelial cells during physiologic shear flow. Infect. Immun. 69: 2815-2820. doi:10.1128/IAI.69.5.2815-2820.2001. PMID:11292693.
18. Hazen, K.C. 1989. Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells. Infect. Immun. 57: 1894-1900. PMID:2659526.
19. Hazen, K.C. 2004. Relationship between expression of cell surface hydrophobicity protein 1 (CSH1p) and surface hydrophobicity properties of Candida dubliniensis. Curr. Microbiol. 48: 447-451. doi:10.1007/s00284-003-4223-1. PMID:15170242.
20. Hazen, K.C., Mandell, G., Coleman, E., and Wu, G. 2000. Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans. FEMS Microbiol. Lett. 183: 89-94. doi:10.1111/j.1574-6968.2000.tb08938.x. PMID:10650207.
21. Hazen, K.C., Wu, J.G., and Masuoka, J. 2001. Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis. Infect. Immun. 69: 779-786. doi:10.1128/IAI.69.2.779- 786.2001. PMID:11159968.
22. Jabra-Rizk, M.A., Falkler, W.A., Jr., Merz, W.G., Kelley, J.I., Baqui, A.A.M.A., and Meiller, T.F. 1999. Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation. Rev. Iberoam. Micol. 16: 187-193. PMID:18473545.
23. Jabra-Rizk, M.A., Falkler, W.A., and Meiller, T.F. 2004. Fungal biofilms and drug resistance. Emerg. Infect. Dis. 10: 14-19. PMID:15078591.
24. Jain, N., Kohli, R., Cook, E., Gialanella, P., Chang, T., and Fries, B.C. 2007. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl. Environ. Microbiol. 73: 1697-1703. doi:10.1128/AEM.02439-06. PMID:17261524.
25. Karahan, Z.C., Güriz, H., ACrossed d signirbali, H., Balaban, N., Göçmen, J.S., Aysev, D., et al. 2004. Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness. Mycoses, 47: 465-469. doi:10.1111/j.1439-0507.2004.01022.x. PMID:15601450.
26. Kennedy, M.J., and Sandin, R.L. 1988. Influence of growth conditions on Candida albicans adhesion, hydrophobicity and cell wall ultrastructure. J. Med. Vet. Mycol. 26: 79-92. doi:10.1080/02681218880000121. PMID:3047356.
27. Klotz, S.A., Drutz, D.J., and Zajic, J.E. 1985. Factors governing adherence of Candida species to plastic surfaces. Infect. Immun. 50: 97-101. PMID:3899942.
28. Kojic, E.M., and Darouiche, R.O. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17: 255-267. doi:10.1128/CMR.17.2. 255-267.2004. PMID:15084500.
29. Kuhn, D.M., George, T., Chandra, J., Mukherjee, P.K., and Ghannoum, M.A. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46: 1773-1780. doi:10.1128/AAC.46.6.1773-1780.2002. PMID:12019089.
30. Li, X., Yan, Z., and Xu, J. 2003. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology, 149: 353-362. doi:10.1099/mic.0.25932-0. PMID:12624197.
31. Masuoka, J., Wu, G., Glee, P.M., and Hazen, K.C. 1999. Inhibition of Candida albicans attachment to extracellular matrix by antibodies which recognize hydrophobic cell wall proteins. FEMS Immunol. Med. Microbiol. 24: 421-429. doi:10.1111/j.1574-695X.1999.tb01314.x. PMID:10435761.
32. McCullough, M.J., Clemons, K.V., and Stevens, D.A. 1999. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J. Clin. Microbiol. 37: 417-421. PMID:9889231.
33. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS Doc. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
34. Nett, J., and Andes, D. 2006. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr. Opin. Microbiol. 9: 340-345. doi:10.1016/j.mib.2006.06.007. PMID:16815078.
35. Ramage, G., Martínez, J.P., and López-Ribot, J.L. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6: 979-986. doi:10.1111/j.1567-1364.2006.00117. x. PMID:17042747.
36. Richards, M.J., Edwards, J.R., Culver, D.H., and Gaynes, R.P. 2000. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 21: 510-515. doi:10.1086/501795. PMID:10968716.
37. Seidler, M., Salvenmoser, S., and Müller, F.M. 2006. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int. J. Antimicrob. Agents, 28: 568-573. doi:10.1016/j.ijantimicag.2006.07.024. PMID:17101265.
38. Stokes, C., Moran, G.P., Spiering, M.J., Cole, G.T., Coleman, D.C., and Sullivan, D.J. 2007. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet. Biol. 44: 920-931. doi:10.1016/j.fgb.2006.11.014. PMID:17251042.
39. Sugita, T., Kurosaka, S., Yajitate, M., Sato, H., and Nishikawa, A. 2002. Extracellular proteinase and phospholipase activity of three genotypic strains of a human pathogenic yeast, Candida albicans. Microbiol. Immunol. 46: 881-883. PMID:12597363.
40. Tamura, M., Watanabe, K., Mikami, Y., Yazawa, K., and Nishimura, K. 2001. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J. Clin. Microbiol. 39: 4309-4315. doi:10.1128/JCM.39.12.4309-4315.2001. PMID:11724837.
41. Thein, Z.M., Samaranayake, Y.H., and Samaranayake, L.P. 2007. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. Arch. Oral Biol. 52: 761-767. doi:10.1016/j.archoralbio.2007.01.009. PMID:17321487.
42. Tortorano, A.M., Kibbler, C., Peman, J., Bernhardt, H., Klingspor, L., and Grillot, R. 2006. Candidaemia in Europe: epidemiology and resistance. Int. J. Antimicrob. Agents, 27: 359-366. doi:10.1016/j.ijantimicag.2006.01. 002. PMID:16647248.
43. Tumbarello, M., Posteraro, B., Trecarichi, E.M., Fiori, B., Rossi, M., Porta, R., et al. 2007. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45: 1843-1850. doi:10.1128/JCM.00131-07. PMID:17460052.